Trump's NIH pick Bhattacharya's challenges to include research funding cuts
President Donald Trump's nominee to lead the National Institutes of Health, vocal U.S. COVID-19 policy critic Dr. Jay Bhattacharya, is widely expected to advance after facing questions on Wednesday in a Senate committee confirmation hearing.
The Trump administration’s orders have created more turmoil and damage at the National Institutes of Health than was ...
The NIH cancelled an internship program that gave more than 1,000 college students hands-on research training each summer ...
Several scientists studying LGBTQ+ health issues have had their grants from the National Institutes of Health (NIH) canceled ...
Senate Republicans seem to be cruising toward confirming as the director of the National Institutes of Health an academic who ...
4don MSN
Administration officials pressured the NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.
In the past few weeks, the Trump administration has attempted to set a cap for indirect costs of medical research paid for by the National Institute of Health’s (NIH) at 15%.
With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.
Judges criticized Jay Bhattacharya's expert witness testimony as untrustworthy, but a Stanford colleague described him as a ...
Despite multiple lawsuits filed by state attorneys general and a temporary block imposed by a federal judge, many ...
The 2024 rankings of the leading research institutions for total NIH funding are now available. Once again, Johns Hopkins ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback